BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27260937)

  • 21. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting opioid initiation in US nursing homes.
    Hunnicutt JN; Hume AL; Ulbricht CM; Tjia J; Lapane KL
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):31-38. PubMed ID: 29869441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study.
    Daniels B; Luckett T; Holliday S; Liauw W; Lovell M; Phillips J; Rowett D; John TN; Tervonen H; Pearson SA
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):68-78. PubMed ID: 32924282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries.
    Ponté C; Lepelley M; Boucherie Q; Mallaret M; Lapeyre Mestre M; Pradel V; Micallef J
    Drug Alcohol Depend; 2018 Jun; 187():88-94. PubMed ID: 29649695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing use of opioids for pain.
    Fredheim OM
    Eur J Pain; 2014 Oct; 18(9):1219-20. PubMed ID: 25195682
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of long-term use of prescription opioids in the community-dwelling population of adults without a cancer diagnosis: a retrospective cohort study.
    Béliveau A; Castilloux AM; Tannenbaum C; Vincent P; de Moura CS; Bernatsky S; Moride Y
    CMAJ Open; 2021; 9(1):E96-E106. PubMed ID: 33563639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical Claims.
    Blanch B; Degenhardt L; Buckley NA; Gisev N; Dobbins T; Karanges EA; Larance B; Larney S; Pearson SA
    Pain Med; 2018 Jun; 19(6):1170-1183. PubMed ID: 28402570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data.
    Middleton M; Nielsen S
    Int J Drug Policy; 2019 Dec; 74():170-173. PubMed ID: 31622949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland.
    Ruscitto A; Smith BH; Guthrie B
    Eur J Pain; 2015 Jan; 19(1):59-66. PubMed ID: 24807782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment.
    Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):587-591. PubMed ID: 28101968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D.
    Suda KJ; Smith BM; Bailey L; Gellad WF; Huo Z; Burk M; Cunningham F; Stroupe KT
    J Am Pharm Assoc (2003); 2017; 57(3):333-340.e3. PubMed ID: 28408172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance.
    Jeffery MM; Chaisson CE; Hane C; Rumanes L; Tucker J; Hang L; McCoy R; Chen CL; Bicket MC; Hooten WM; Larochelle M; Becker WC; Kornegay C; Racoosin JA; Sanghavi D
    JAMA Netw Open; 2020 Apr; 3(4):e202875. PubMed ID: 32293684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cohort profile: POPPY II - a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia.
    Gisev N; Pearson SA; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow DC; Mattick RP; Degenhardt L
    BMJ Open; 2023 May; 13(5):e068310. PubMed ID: 37197812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial.
    Ashaye T; Hounsome N; Carnes D; Taylor SJC; Homer K; Eldridge S; Spencer A; Rahman A; Foell J; Underwood MR;
    BMJ Open; 2018 Jun; 8(6):e019491. PubMed ID: 29880563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographic Variation in the Initiation of Commonly Used Opioids and Dosage Strength in United States Nursing Homes.
    Hunnicutt JN; Baek J; Alcusky M; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
    Med Care; 2018 Oct; 56(10):847-854. PubMed ID: 30113423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
    Ponizovsky AM; Marom E; Weizman A; Schwartzberg E
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine transdermal system utilization.
    Wallace L; Kadakia A
    Postgrad Med; 2017 Jan; 129(1):81-86. PubMed ID: 27901359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study.
    Nielsen S; Campbell G; Peacock A; Smith K; Bruno R; Hall W; Cohen M; Degenhardt L
    Aust Health Rev; 2016 Nov; 40(5):490-499. PubMed ID: 26599263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.